Prof Ori Ben-Yehuda
University of California, San Diego
ארצות הברית
Ori Ben-Yehuda, MD, is a Professor of Medicine and the Joanne C. Warren Chair in Cardiovascular Disease at the University of California, San Diego. He is board-certified cardiologist who specializes in the treatment of coronary artery disease, myocardial infarction, heart failure, and valvular heart disease. He serves as the director of the Cardiovascular Outcomes Group at the UC San Diego Health Cardiovascular Institute. Dr. Ben-Yehuda has played a leading role in development of medical devices including stents, trans-catheter valves, and innovative device therapies for heart failure.
Ori Ben-Yehuda, MD, is a Professor of Medicine and the Joanne C. Warren Chair in Cardiovascular Disease at the University of California, San Diego. He is board-certified cardiologist who specializes in the treatment of coronary artery disease, myocardial infarction, heart failure, and valvular heart disease. He serves as the director of the Cardiovascular Outcomes Group at the UC San Diego Health Cardiovascular Institute. Dr. Ben-Yehuda earned his medical degree magna cum laude from Tel Aviv University in Israel. He completed his residency in internal medicine at Ben-Gurion University in Be’er Sheva, Israel, and at New York University Medical Center/ Bellevue Hospital, where he served as Chief Resident. He then completed a cardiovascular fellowship and a research fellowship in atherosclerosis at the University of California, San Diego. Following his cardiology training Dr. Ben-Yehuda was appointed as the Director of the Coronary Care Unit, a position he held until 2011. Dr. Ben-Yehuda has served as Deputy Editor of The Journal of the American College of Cardiology and Structural Heart: The Journal of the Heart Team, as well as Editor-in-Chief of Coronary Artery Disease. Dr. Ben-Yehuda has played a leading role in development of medical devices including stents, trans-catheter valves, and innovative device therapies for heart failure. His current research interests include clinical trial design, heart failure device therapies, inflammation and atherosclerosis, lipid-lowering strategies, as well as outcome research.